Medicare Part B Step Therapy Rituximab Products
Customize your policy alerts
Sign up for zing_health Policy 5328-D alerts
Get alerted when Policy 5328-D changes without checking for updates manually.
Monitor payer policy activity
This policy governs preferred-product sequencing and prior authorization exceptions for Zing Health Medicare Part B members requesting rituximab products. Non-preferred products may be covered when specified prior-use or intolerance criteria are met, in addition to applicable Medicare coverage and utilization management requirements.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.